vs
MidWestOne Financial Group, Inc.（MOFG）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是MidWestOne Financial Group, Inc.的1.2倍（$75.5M vs $61.3M），MidWestOne Financial Group, Inc.同比增速更快（35.9% vs 27.7%），MidWestOne Financial Group, Inc.自由现金流更多（$16.7M vs $14.4M），过去两年MidWestOne Financial Group, Inc.的营收复合增速更高（37.2% vs 31.3%）
中西部一号金融集团是一家银行控股公司，总部位于美国爱荷华城。集团旗下共运营56家分行，是总部设于爱荷华州的第三大银行，业务覆盖爱荷华州、明尼苏达州、威斯康星州、科罗拉多州以及佛罗里达州。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
MOFG vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$61.3M
营收增速更快
MOFG
高出8.2%
27.7%
自由现金流更多
MOFG
多$2.4M
$14.4M
两年增速更快
MOFG
近两年复合增速
31.3%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.3M | $75.5M |
| 净利润 | $17.0M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 35.1% | 22.7% |
| 净利率 | 27.8% | — |
| 营收同比 | 35.9% | 27.7% |
| 净利润同比 | 117.8% | — |
| 每股收益（稀释后） | $0.82 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MOFGPBYI
| Q4 25 | — | $75.5M | ||
| Q3 25 | $61.3M | $54.5M | ||
| Q2 25 | $60.2M | $52.4M | ||
| Q1 25 | $57.6M | $46.0M | ||
| Q4 24 | $48.9M | $59.1M | ||
| Q3 24 | $37.5M | $80.5M | ||
| Q2 24 | $57.9M | $47.1M | ||
| Q1 24 | $44.5M | $43.8M |
净利润MOFGPBYI
| Q4 25 | — | — | ||
| Q3 25 | $17.0M | $8.8M | ||
| Q2 25 | $10.0M | $5.9M | ||
| Q1 25 | $15.1M | $3.0M | ||
| Q4 24 | $16.3M | — | ||
| Q3 24 | $-95.7M | $20.3M | ||
| Q2 24 | $15.8M | $-4.5M | ||
| Q1 24 | $3.3M | $-4.8M |
毛利率MOFGPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率MOFGPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | 35.1% | 17.6% | ||
| Q2 25 | 20.9% | 12.7% | ||
| Q1 25 | 34.0% | 8.7% | ||
| Q4 24 | 43.1% | 22.6% | ||
| Q3 24 | -347.0% | 27.4% | ||
| Q2 24 | 36.0% | -4.6% | ||
| Q1 24 | 9.5% | -5.3% |
净利率MOFGPBYI
| Q4 25 | — | — | ||
| Q3 25 | 27.8% | 16.2% | ||
| Q2 25 | 16.6% | 11.2% | ||
| Q1 25 | 26.3% | 6.5% | ||
| Q4 24 | 33.4% | — | ||
| Q3 24 | -255.1% | 25.2% | ||
| Q2 24 | 27.3% | -9.6% | ||
| Q1 24 | 7.3% | -11.0% |
每股收益（稀释后）MOFGPBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | $0.82 | $0.17 | ||
| Q2 25 | $0.48 | $0.12 | ||
| Q1 25 | $0.73 | $0.06 | ||
| Q4 24 | $1.30 | $0.40 | ||
| Q3 24 | $-6.05 | $0.41 | ||
| Q2 24 | $1.00 | $-0.09 | ||
| Q1 24 | $0.21 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $98.0M | $22.7M |
| 股东权益账面价值 | $606.1M | $130.3M |
| 总资产 | $6.2B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.16× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资MOFGPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务MOFGPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | $98.0M | $34.0M | ||
| Q2 25 | $112.3M | $45.3M | ||
| Q1 25 | $111.4M | $56.7M | ||
| Q4 24 | $113.4M | $68.0M | ||
| Q3 24 | $115.1M | $79.3M | ||
| Q2 24 | $114.8M | $90.7M | ||
| Q1 24 | $122.1M | $102.0M |
股东权益MOFGPBYI
| Q4 25 | — | $130.3M | ||
| Q3 25 | $606.1M | $115.3M | ||
| Q2 25 | $589.0M | $104.7M | ||
| Q1 25 | $579.6M | $97.1M | ||
| Q4 24 | $559.7M | $92.1M | ||
| Q3 24 | $562.2M | $71.1M | ||
| Q2 24 | $543.3M | $48.5M | ||
| Q1 24 | $528.0M | $51.0M |
总资产MOFGPBYI
| Q4 25 | — | $216.3M | ||
| Q3 25 | $6.2B | $202.9M | ||
| Q2 25 | $6.2B | $194.9M | ||
| Q1 25 | $6.3B | $196.2M | ||
| Q4 24 | $6.2B | $213.3M | ||
| Q3 24 | $6.6B | $220.7M | ||
| Q2 24 | $6.6B | $205.0M | ||
| Q1 24 | $6.7B | $214.1M |
负债/权益比MOFGPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | 0.16× | 0.30× | ||
| Q2 25 | 0.19× | 0.43× | ||
| Q1 25 | 0.19× | 0.58× | ||
| Q4 24 | 0.20× | 0.74× | ||
| Q3 24 | 0.20× | 1.12× | ||
| Q2 24 | 0.21× | 1.87× | ||
| Q1 24 | 0.23× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $16.7M | $14.4M |
| 自由现金流率自由现金流/营收 | 27.3% | 19.1% |
| 资本支出强度资本支出/营收 | 1.5% | 0.0% |
| 现金转化率经营现金流/净利润 | 1.04× | — |
| 过去12个月自由现金流最近4个季度 | $109.6M | $41.7M |
8季度趋势，按日历期对齐
经营现金流MOFGPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | $17.7M | $9.7M | ||
| Q2 25 | $24.9M | $14.1M | ||
| Q1 25 | $8.7M | $3.6M | ||
| Q4 24 | $63.2M | $15.6M | ||
| Q3 24 | $-2.8M | $11.0M | ||
| Q2 24 | $25.2M | $1.0M | ||
| Q1 24 | $9.6M | $11.2M |
自由现金流MOFGPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | $16.7M | $9.7M | ||
| Q2 25 | $23.8M | $14.1M | ||
| Q1 25 | $8.3M | $3.6M | ||
| Q4 24 | $60.8M | $15.6M | ||
| Q3 24 | $-3.0M | $11.0M | ||
| Q2 24 | $24.6M | $1.0M | ||
| Q1 24 | $9.1M | — |
自由现金流率MOFGPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | 27.3% | 17.7% | ||
| Q2 25 | 39.5% | 26.8% | ||
| Q1 25 | 14.4% | 7.7% | ||
| Q4 24 | 124.2% | 26.4% | ||
| Q3 24 | -7.9% | 13.7% | ||
| Q2 24 | 42.5% | 2.1% | ||
| Q1 24 | 20.4% | — |
资本支出强度MOFGPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | 1.5% | 0.0% | ||
| Q2 25 | 1.9% | 0.0% | ||
| Q1 25 | 0.7% | 0.1% | ||
| Q4 24 | 4.9% | 0.0% | ||
| Q3 24 | 0.6% | 0.0% | ||
| Q2 24 | 1.1% | 0.0% | ||
| Q1 24 | 1.2% | 0.0% |
现金转化率MOFGPBYI
| Q4 25 | — | — | ||
| Q3 25 | 1.04× | 1.10× | ||
| Q2 25 | 2.50× | 2.41× | ||
| Q1 25 | 0.57× | 1.21× | ||
| Q4 24 | 3.87× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 1.60× | — | ||
| Q1 24 | 2.93× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
